MedTrace Logo

Trial of IRE in Cholangiocarcinoma

NCT03769753 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2022-09-10

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to test any good and bad side effects of surgery using IRE to treat cancer of the bile duct.

Conditions

Interventions

DEVICE

IRE Device

For use in ablating soft tissue

Sponsors & Collaborators

Principal Investigators

  • T. Peter Kingham, MD · Memorial Sloan Kettering Cancer Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-05
Primary Completion
2021-08-16
Completion
2021-08-16
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03769753 on ClinicalTrials.gov